A Study to Evaluate ENERGI-F703 GEL in Venous Leg Ulcer
Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled, phase II, multi-centered study to
evaluate the efficacy and safety of ENERGI-F703 GEL in subjects who are ≥ 20 years old with
venous leg ulcer (VLU). Subjects will be recruited from multiple sites in Taiwan. The
treatment period will be 84 days with another 84-day follow-up period.